Rapid monitoring of SARS-CoV-2 variants in the United States
Early indications of emerging variants using PCR-based technology
Learn more about the collaboration with Thermo Fisher Scientific, the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind to develop a new genotyping method designed to accelerate the identification of SARS-CoV-2 variants as they emerge.
- Jeremy Davis-Turak, PhD, Chief Technology Officer of Rosalind
- Manoj Ghandhi, MD, PhD, Sr. Director of Medical and Scientific Affairs, Genetic Testing Solutions, Thermo Fisher Scientific
* Required field